John David Hansen's Net Worth
$268 Thousand
Who is John David Hansen?
John David Hansen does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include AVANIR PHARMACEUTICALS, and MABVAX THERAPEUTICS HOLDINGS, INC..
SEC CIK
John David Hansen's CIK is 0001186123
Past Insider Trading and Trends
2017 was John David Hansen's most active year for acquiring shares with 8 total transactions. John David Hansen's most active month to acquire stocks was the month of March. 2017 was John David Hansen's most active year for disposing of shares, totalling 10 transactions. John David Hansen's most active month to dispose stocks was the month of March. 2015 saw John David Hansen paying a total of $2,077,475.00 for 1,806,500 shares, this is the most they've acquired in one year. In 2018 John David Hansen cashed out on 997,413 shares for a total of $240,784.66, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AVANIR PHARMACEUTICALS No price found
V.P. Corporate Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -50.00% | -30.00K |
$3.41 | -$102,029.76 | 30K |
Scheduled
|
Jan 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 10
| |||
Form 4
| -33.33% | -30.00K |
$3.15 | -$94,518.00 | 60K |
Scheduled
|
Sep 13
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 6
| |||
| No matching records found | |||||||||
MABVAX THERAPEUTICS HOLDINGS, INC. No price found
PRESIDENT AND CEOJohn David Hansen owns 190,827 units of Common Stock. From 2014 to 2018 John David Hansen acquired a total of 1,094,789 shares in MABVAX THERAPEUTICS HOLDINGS, INC. at a cost of $7,500.50, John also disposed a total of 386,533 shares of MABVAX THERAPEUTICS HOLDINGS, INC. equalling to $275,142.09.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +4.88% | 8.87K |
—
|
—
| 190.83K |
Apr 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
| -9.94% | -59.26K |
$0.92 | -$54,521.96 | 536.73K |
Jan 16
| |||
Form 4
| +869.52% | 534.52K |
$0.97 | -$186,262.70 | 595.99K |
Jan 8 - Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 4
| +14.85% | 9.13K |
$1.75 |
—
| 70.6K |
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
| -14.25% | -10.22K |
$2.00 | -$20,433.02 | 61.47K |
Apr 12
| |||
Form 4
| -2.02% | -1.48K |
$2.00 | -$2,955.33 | 71.69K |
Apr 7 - Apr 11
| |||
Form 4
| -6.46% | -5.05K |
$2.17 | -$10,969.08 | 73.17K |
Apr 4 - Apr 6
| |||
Form 4
| +108.41% | 40.69K |
—
|
—
| 78.22K |
Apr 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 29
| |||
Form 4
| +9.06% | 3.12K |
—
|
—
| 37.53K |
Aug 17
| |||
Form 4
| +281.77% | 187.94K |
—
|
—
| 254.63K |
Apr 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||